Liver injury induced by the non-steroidal anti-inflammatory drug mefenamic acid

Singapore Medical Journal

Volumn 45, Issue 11, 2004, Pages 530-532

  Somchit, Nhareet ^a   Sanat, F ^a   Gan, E H ^a   Shahrin, I A W ^b   Zuraini, A ^a  

^a Universiti Putra Malaysia   (Malaysia)

^b Department of Clinical Laboratories ^*

Author keywords

Hepatotoxicity; Liver; Mefenamic acid; Non steroidal anti inflammatory drug

Indexed keywords

ALANINE AMINOTRANSFERASE; MEFENAMIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEGENERATION; CONTROLLED STUDY; DOSE RESPONSE; HEPATITIS; HISTOPATHOLOGY; INFLAMMATION; LIVER DEGENERATION; LIVER INJURY; LIVER NECROSIS; LIVER PARENCHYMA; LIVER TOXICITY; LIVER WEIGHT; MALE; MOUSE; MUSCULOSKELETAL DISEASE; NONHUMAN; PAIN;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DOSE-RESPONSE RELATIONSHIP, DRUG; LIVER; LIVER DISEASES; MALE; MEFENAMIC ACID; MICE; MICE, INBRED BALB C; MODELS, ANIMAL;

EID: 9444229982     PISSN: 00375675     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Rang HP, Dale MM, Ritter JM. Pharmacology. 3rd. ed. New York: Churchill Livingstone, 1995.
2. Baum C, Kennedy DL, Forbes MB. Utilization of nonsteroidal antiinflammatory drugs. Arthritis Rheum 1985; 28:686-92.
3. O'Brien WM. Rare adverse reaction to non-steroidal anti-inflammatory drugs. In: Rainsford KD, Velo GP, eds. Side Effects of Anti-inflammatory Drugs, Part 1: Clinical and Epidemiological Aspects. 1st ed, Lancaster: MTP Press, 1987.
4. Barr M, Buckley M, O'Morain C. Non-steroidal anti-inflammatory drugs and Helicobacter pylori. Aliment Pharmacol Ther 2000; 14 Suppl 3:43-7.
5. Bus PJ, Verspaget HW, Lamers CB, Griffioen G. Chemoprevention of colorectal cancer by non-steroidal anti-inflammatory drugs. Scand J Gastroenterol Suppl 2000; 232:101-4
6. Giovannucci E, Egan KM, Hunter DJ, Stampfer MJ, Colditz GA, Willett WC, et al. Aspirin and the risk of colorectal cancer in women. N Engl J Med 1995; 333:609-14.
7. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med; 328:1313-6.
8. Wade LT, Kenna JG, Caldwell J. Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal antiinflammatory drugs diclofenac, sulindac, and ibuprofen. Chem Res Toxicol 1997; 10:546-55.
9. Boelsterli UA, Zimmerman HJ, Kretz-Rommel A. Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology. Crit Rev Toxicol 1995; 25:207-35.
10. Katzung BG, ed. Basic and Clinical Pharmacology. 8th ed. New York:McGraw-Hill, 2001.
11. Mingatto FE, Santos AC, Uyemura SA, Jordani MC, Curti C. In vitro interaction of nonsteroidal anti-inflammatory drugs on oxidative phosphorylation of rat kidney mitochondria: respiration and ATP synthesis. Arch Biochem Biophys 1996; 334:303-8.
12. Uyemura SA, Santos AC, Mingatto FE, Jordani MC, Curti C. Diclofenac sodium and mefenamic acid: potent inducers of the membrane permeability transition in renal cortex mitochondria. Arch Biochem Biophys 1997; 343:231-5.